We are reviewing claims of patients diagnosed with cancer after using Zantac (ranitidine).

Contact us for a case evaluation



Did you use any of the following medications?

Do you reside on California, Illinois, Massachusetts, or Vermont?

Did you take the medication for more than 3 months?

Have you been diagnosed with any of the following after using Zantac/Ranitidine?


Zantac No Longer Available in U.S. Due to Cancer-Causing Contaminant

In April 2020, the U.S. Food and Drug Administration announced the agency had requested manufacturers of prescription and over-the-counter ranitidine (Zantac) medications immediately withdraw the medication from the market. As part of an ongoing investigation, public health officials determined the medication exposes consumers to unacceptable levels of the carcinogen N-Nitrosodimethylamine (NDMA).

FDA Requests All Ranitidine (Zantac) Products Pulled from Market

  • Prescription and over-the-counter ranitidine products (Zantac) are no longer available in the United States
  • In April 2020, the U.S. Food and Drug Administration requested manufacturers immediately withdraw all ranitidine products from the U.S. market
  • In 2019, retailers including CVS, Walgreens, and Walmart pulled ranitidine products from their shelves



FDA Studies Confirm: NDMA Levels in Zantac Increase Under Normal Storage Conditions

U.S. Food and Drug administration testing and evaluation confirm that levels of the carcinogen N-Nitrosodimethylamine, (NDMA) in ranitidine medications (Zantac) increase even under ordinary storage conditions. NDMA levels increase even more significantly when the medication is exposed to higher temperatures, including during distribution and handling by consumers.

NDMA levels were also found to increase the older the products were, and the longer time had passed since manufacturing.

NDMA is classified as a Probable Human Carcinogen

NDMA is classified by the International Agency for Research on Cancer (IARC) as a Class 2A probable human carcinogen based on laboratory test results.


Disclaimer: This is an attorney advertisement. Napoli Shkolnik, PLLC, 360 Lexington Avenue, 11th Floor New York, NY 10017. Information presented here should not be construed to be formal legal advice, nor is it providing information for the formation of an attorney-client relationship. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. This advertisement is not intended as a testimonial, endorsement, or dramatization and does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter, either express or implied. Neither the firm nor this advertisement are affiliated with, sponsored, endorsed or approved by the drug manufacturers. The choice of a lawyer is an important decision that should not be based solely on advertisements. Prior results do not guarantee similar outcomes. Do not rely on this advertisement in making any medical decisions. Please speak with your physician before making any medical decision, including altering your use of any drug or treatment they have prescribed for you.